ChartRow logo
Share this page
VKTX
$25.17-8.04%
as of close, Oct 16, 2026
☾ AH $25.17 -8.04%
PeersMRNALLYMDTUNHJNJTMO

Viking Therapeutics Inc. total returns by year (including dividends)

As of market close, Oct 16, 2026

Viking Therapeutics Inc. total returns by year (2016–2026)#

Viking Therapeutics Inc. annual returns by year
YearTotal return
2026YTD
-28.5%
2025
-12.6%
2024
+116.2%
2023
+98.0%
2022
+104.3%
2021
-18.3%
2020
-29.8%
2019
+4.8%
2018
+88.4%
2017
+241.2%
2016
-65.1%
Annualized
+9.6%
2016–2026
Average year
+52.7%
10 full years
Best year
+241.2%
2017
Worst year
-65.1%
2016
Positive years
6/10
60% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on VKTX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Viking Therapeutics Inc.'s average annual return?
Since 2016, Viking Therapeutics Inc. (VKTX) has returned about 9.6% a year (the compound annual growth rate) and an average calendar-year return of 52.7%.
What were Viking Therapeutics Inc.'s best and worst years?
Over 2016–2026, the best year was 2017 (+241.2%) and the worst was 2016 (-65.1%).
How often is Viking Therapeutics Inc. up in a year?
6 of the 10 full years since 2016 were positive — about 60% of the time.

More on Viking Therapeutics Inc.